Clarus, the pharmaceutical company that makes Jatenzo, a recently introduced oral formulation of testosterone, has been sued by Lipocine, the company that makes Tlando, a rival oral formulation candidate, for patent violations. Tlando has been denied approval for sale three times by the FDA, but...